Efficacy and Safety of Switching to Pasireotide in Patients With Acromegaly Controlled With Pegvisomant and First-Generation Somatostatin Analogues (PAPE Study)
Muhammad, Ammar, van der Lely, Aart J, Delhanty, Patric J D, Dallenga, Alof H G, Haitsma, Iain K, Janssen, Joseph A M J L, Neggers, Sebastian J C M MVolume:
103
Langue:
english
Journal:
The Journal of Clinical Endocrinology & Metabolism
DOI:
10.1210/jc.2017-02017
Date:
February, 2018
Fichier:
PDF, 528 KB
english, 2018
File converter
Plus de résultats de recherche
More benefits 
